应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LLY 礼来
未开盘 07-09 16:00:00 EDT
786.92
+9.26
+1.19%
盘后
787.78
+0.86
+0.11%
19:59 EDT
最高
794.00
最低
781.99
成交量
270.31万
今开
783.80
昨收
777.66
日振幅
1.54%
总市值
7,458亿
流通市值
7,436亿
总股本
9.48亿
成交额
21.27亿
换手率
0.29%
流通股本
9.45亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
礼来7月9日成交额为21.27亿美元
市场透视 · 03:21
礼来7月9日成交额为21.27亿美元
美国FDA批准礼来阿尔茨海默症药物逐步给药以降低脑肿胀风险
格隆汇 · 07-09 13:09
美国FDA批准礼来阿尔茨海默症药物逐步给药以降低脑肿胀风险
【大摩:Hims(HIMS.US)目标价40美元存18%下行空间,GLP-1诉讼拉锯战成最大变数】智通财经APP获悉,大
智通财经 · 07-09 07:57
【大摩:Hims(HIMS.US)目标价40美元存18%下行空间,GLP-1诉讼拉锯战成最大变数】智通财经APP获悉,大
礼来7月8日成交额为25.81亿美元
市场透视 · 07-09 03:19
礼来7月8日成交额为25.81亿美元
美股医药板块股票走高Moderna涨超10%礼来、辉瑞涨超2%诺和诺德涨超1%。
智通财经 · 07-08 15:24
美股医药板块股票走高Moderna涨超10%礼来、辉瑞涨超2%诺和诺德涨超1%。
【美股异动 | 医药板块股票走高 Moderna(MRNA.US)涨超9%】智通财经APP获悉,周二,美股医药板块股票走
智通财经 · 07-08 14:56
【美股异动 | 医药板块股票走高 Moderna(MRNA.US)涨超9%】智通财经APP获悉,周二,美股医药板块股票走
礼来7月7日成交额为19.85亿美元
市场透视 · 07-08 03:17
礼来7月7日成交额为19.85亿美元
预测:2030年畅销药和世界药企排名
谈思生物 · 07-07
预测:2030年畅销药和世界药企排名
伴随着国产GLP-1减重药玛仕度肽(商品名:信尔美)的商业化落地国内减重药市场格局迎来了新的变化。全球两大减重药巨头诺和
智通财经 · 07-06
伴随着国产GLP-1减重药玛仕度肽(商品名:信尔美)的商业化落地国内减重药市场格局迎来了新的变化。全球两大减重药巨头诺和
减重赛道“人满为患”:中国药企试图“后来居上”?
大洋网 · 07-06
减重赛道“人满为患”:中国药企试图“后来居上”?
从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变
钛媒体APP · 07-04
从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变
从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变
医曜 · 07-03
从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变
太平洋医药日报:礼来替尔泊肽新适应症获批
太平洋证券股份... · 07-03
太平洋医药日报:礼来替尔泊肽新适应症获批
从礼来获悉其GIP/GLP-1药物替尔泊肽注射液获得中国国家药品监督管理局(NMPA)批准成为首个且目前唯一用于治疗成人
智通财经 · 07-03
从礼来获悉其GIP/GLP-1药物替尔泊肽注射液获得中国国家药品监督管理局(NMPA)批准成为首个且目前唯一用于治疗成人
礼来替尔泊肽获批第三项适应证 填补睡眠呼吸暂停药物治疗领域空白
格隆汇 · 07-03
礼来替尔泊肽获批第三项适应证 填补睡眠呼吸暂停药物治疗领域空白
礼来宣布穆峰达(替尔泊肽注射液)获得中国国家药品监督管理局(NMPA)批准成为首个且目前唯一用于治疗成人肥胖患者的中度至
智通财经 · 07-03
礼来宣布穆峰达(替尔泊肽注射液)获得中国国家药品监督管理局(NMPA)批准成为首个且目前唯一用于治疗成人肥胖患者的中度至
重磅!礼来“替尔泊肽”又一适应症在华获批
Insight数据库 · 07-03
重磅!礼来“替尔泊肽”又一适应症在华获批
礼来7月2日成交额为15.37亿美元
市场透视 · 07-03
礼来7月2日成交额为15.37亿美元
周三(7月2日)美国科技股七巨头(Magnificent 7)指数涨1.26%报173.68点。特斯拉收涨4.97%脱离
智通财经 · 07-02
周三(7月2日)美国科技股七巨头(Magnificent 7)指数涨1.26%报173.68点。特斯拉收涨4.97%脱离
加载更多
公司概况
公司名称:
礼来
所属市场:
NYSE
上市日期:
--
主营业务:
礼来公司于1901年在印第安纳州注册成立,其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现,开发,制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来,为世界各地的人们创造更美好的生活。
发行价格:
--
{"stockData":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"礼来","latestPrice":786.92,"timestamp":1752091200000,"preClose":777.66,"halted":0,"volume":2703085,"hourTrading":{"tag":"盘后","latestPrice":787.7832,"preClose":786.92,"latestTime":"19:59 EDT","volume":182115,"amount":143294295.854899,"timestamp":1752105574217},"delay":0,"floatShares":944999999,"shares":947735651,"eps":12.289877,"marketStatus":"未开盘","change":9.26,"latestTime":"07-09 16:00:00 EDT","open":783.8,"high":794,"low":781.99,"amount":2127147599.2305,"amplitude":0.015444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":12.289877,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752134400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":102488400000,"exchange":"NYSE","adjPreClose":777.66,"dividendRate":0.006862,"preHourTrading":{"tag":"盘前","latestPrice":784.2,"preClose":778.32,"latestTime":"09:29 EDT","volume":5299,"amount":4140340.2663000003,"timestamp":1752067799999},"postHourTrading":{"tag":"盘后","latestPrice":787.7832,"preClose":786.92,"latestTime":"19:59 EDT","volume":182115,"amount":143294295.854899,"timestamp":1752105574217},"volumeRatio":1.122386,"optionData":{"bulkOrders":[{"symbol":"LLY","call":true,"expireDate":1755230400000,"strike":"960.0","timestamp":1752088455460,"price":4.3,"volume":1850,"amount":795500,"type":"+"},{"symbol":"LLY","call":true,"expireDate":1755230400000,"strike":"850.0","timestamp":1752088455460,"price":21,"volume":1850,"amount":3885000,"type":"+"}]},"impliedVol":0.4477,"impliedVolPercentile":0.86},"requestUrl":"/m/hq/s/LLY","defaultTab":"news","newsList":[{"id":"2550699741","title":"礼来7月9日成交额为21.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550699741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550699741?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:21","pubTimestamp":1752117693,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,礼来成交额为21.27亿美元,成交额较昨日减少17.59%,当日成交量为270.31万股。礼来于2025年7月9日涨1.19%,报786.92美元,该股过去5个交易日涨1.42%,年初至今涨2.31%,过去60日涨9.38%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-09|21.27亿|-17.59%|270.31万|#|2025-07-08|25.81亿|30.04%|330.18万|#|2025-07-07|19.85亿|75.62%|257.69万|#|2025-07-03|11.30亿|-26.48%|145.08万|#|2025-07-02|15.37亿|-27.88%|197.83万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710112139a441951c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710112139a441951c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999013999.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0203202063.USD","SGXZ81514606.USD","LU2236285917.USD","LU0316494557.USD","LU2552382058.USD","SGXZ51526630.SGD","LU0256863902.USD","LU0234572021.USD","LLY","BK4007","LU2106854487.HKD","LU0096364046.USD","LU1983299246.USD","LU1280957306.USD","LU0882574139.USD","BK4581","LU2324357040.USD","LU1868837300.USD","LU2237443549.SGD","LU2237438978.USD","LU1023059063.AUD","SG9999018857.SGD","LU2112291526.USD","IE0002141913.USD","LU0708995401.HKD","LU0672654240.SGD","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU1057294990.SGD","LU2471134523.USD","LU2237443895.HKD","LU2237443622.USD","LU0466842654.USD","SG9999017495.SGD","BK4516","LU2265009873.SGD","BK4534","BK4588","LU1814569148.SGD","LU0006306889.USD","LU1069344957.HKD","LU1035775433.USD","LU1712237335.SGD","LU1974910355.USD","LU2361044949.HKD","LU1061106388.HKD","LU0385154629.USD"],"gpt_icon":1},{"id":"2550630764","title":"美国FDA批准礼来阿尔茨海默症药物逐步给药以降低脑肿胀风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2550630764","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550630764?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:09","pubTimestamp":1752066589,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1064131342.USD","LU0096364046.USD","LU2324357040.USD","LU2471134523.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","IE0002141913.USD","LLY","LU0456855351.SGD","LU2236285917.USD","SGXZ81514606.USD","SG9999018865.SGD","LU2357305700.SGD","BK4599","LU1868836757.USD","IE00BK4W5L77.USD","BK4516","LU1035775433.USD","LU1720051108.HKD","LU1548497426.USD","LU1069344957.HKD","SG9999014898.SGD","LU1061106388.HKD","LU1093756325.SGD","LU1232071149.USD","SG9999014906.USD","LU0882574139.USD","LU0097036916.USD","LU0106261372.USD","LU0417517546.SGD","LU1917777945.USD","SG9999015978.USD","SG9999015945.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU1623119135.USD","LU2471134796.USD","LU1868837136.USD","LU2237443465.HKD","GB00BDT5M118.USD","LU0006306889.USD","LU0820561818.USD","LU1720051017.SGD","LU2471134952.CNY","LU0094547139.USD","SG9999001176.USD","LU1804176565.USD","LU1989771016.USD","LU0823416689.USD","LU1868836591.USD"],"gpt_icon":0},{"id":"2550686743","title":"【大摩:Hims(HIMS.US)目标价40美元存18%下行空间,GLP-1诉讼拉锯战成最大变数】智通财经APP获悉,大","url":"https://stock-news.laohu8.com/highlight/detail?id=2550686743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550686743?lang=zh_cn&edition=full","pubTime":"2025-07-09 15:57","pubTimestamp":1752047831,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SGXZ51526630.SGD","LU2089283258.USD","LU1548497426.USD","LU1983299246.USD","SGXZ99366536.SGD","LU0114720955.EUR","LU1868836591.USD","SG9999014906.USD","SG9999001176.SGD","LU2347655156.SGD","NVO","LU1814569148.SGD","SG9999018865.SGD","BK4534","LU1868837300.USD","LU0106831901.USD","BK4581","LU0203202063.USD","LU1868837136.USD","LU2106854487.HKD","LU1720051108.HKD","SG9999001176.USD","BK4533","LU0912757837.SGD","LU0106261372.USD","SG9999018857.SGD","LU1057294990.SGD","159891","LU0006306889.USD","LU0122379950.USD","LU1061106388.HKD","LU1074936037.SGD","LU1868836914.USD","BK4532","LU1291159041.SGD","LU1868836757.USD","LLY","SG9999013999.USD","LU0672654240.SGD","LU2271345857.HKD","LU2746668461.USD","IE0002141913.USD","HIMS","GLP","BK4590","LU2264538146.SGD","LU0314104364.USD","LU0471298777.SGD","SG9999015952.SGD","SG9999014898.SGD"],"gpt_icon":0},{"id":"2550533509","title":"礼来7月8日成交额为25.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550533509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550533509?lang=zh_cn&edition=full","pubTime":"2025-07-09 11:19","pubTimestamp":1752031178,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,礼来成交额为25.81亿美元,成交额较昨日增加30.04%,当日成交量为330.18万股。礼来于2025年7月8日涨0.62%,报777.66美元,该股过去5个交易日跌0.24%,年初至今涨1.11%,过去60日涨3.38%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-08|25.81亿|30.04%|330.18万|#|2025-07-07|19.85亿|75.62%|257.69万|#|2025-07-03|11.30亿|-26.48%|145.08万|#|2025-07-02|15.37亿|-27.88%|197.83万|#|2025-07-01|21.32亿|-10.01%|273.40万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709111944a69e665d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709111944a69e665d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0079474960.USD","LU1989771016.USD","IE00B2B36J28.USD","LU1623119135.USD","LU1720051108.HKD","LU0109391861.USD","LU2552382058.USD","LU0256863902.USD","LU2211815571.USD","SG9999018865.SGD","LU2491050071.SGD","LLY","LU2552382132.HKD","BK4007","LU1093756325.SGD","LU2417539215.USD","LU1804176565.USD","LU1280957306.USD","LU0882574139.USD","LU1093756168.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","SGXZ99366536.SGD","LU1551013425.SGD","LU0122379950.USD","LU0106261372.USD","LU0266013472.USD","LU1232071149.USD","LU2471134879.HKD","SG9999014906.USD","LU0238689110.USD","SG9999018857.SGD","LU1548497426.USD","IE0002141913.USD","LU0708995401.HKD","SG9999015945.SGD","LU2264538146.SGD","LU0640476718.USD","LU0354030438.USD","LU0466842654.USD","LU0061475181.USD","LU0289739699.SGD","BK4588","LU0786609619.USD","LU1127390331.HKD","IE00B1BXHZ80.USD","LU2063271972.USD","LU2746668461.USD","LU0385154629.USD","LU1291159041.SGD"],"gpt_icon":1},{"id":"2549392529","title":"美股医药板块股票走高Moderna涨超10%礼来、辉瑞涨超2%诺和诺德涨超1%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2549392529","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549392529?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:24","pubTimestamp":1751988290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"36aa7b3b0e5d12a0b0767a4494ad1a18","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0321505439.SGD","LU2237443549.SGD","LU2491050154.USD","LU1093756325.SGD","NVO","LU2063271972.USD","LU2211815571.USD","LU2236285917.USD","IE00BK4W5L77.USD","LU2750360997.AUD","LU0316494557.USD","BK4592","SG9999001176.USD","LU0256863902.USD","LU0868494617.USD","BK4532","LU0061475181.USD","LU2112291526.USD","IE0009355771.USD","LU0306806265.USD","LU2357305700.SGD","SG9999014914.USD","LU0708995401.HKD","LU2461242641.AUD","BK1515","LU0106261372.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU0170899867.USD","SG9999002224.SGD","IE0004445239.USD","LU2552382058.USD","LU1551013425.SGD","LU2023250504.SGD","SG9999015978.USD","SG9999001176.SGD","PFE","LU1868836591.USD","09939","LU2491049909.HKD","LU1093756168.USD","LU0882574055.USD","LLY","SG9999015986.USD","LU0238689110.USD","LU2237443465.HKD","159938","IE00BJLML261.HKD","LU0820561818.USD","LU1974910355.USD"],"gpt_icon":0},{"id":"2549269435","title":"【美股异动 | 医药板块股票走高 Moderna(MRNA.US)涨超9%】智通财经APP获悉,周二,美股医药板块股票走","url":"https://stock-news.laohu8.com/highlight/detail?id=2549269435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549269435?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:56","pubTimestamp":1751986600,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"36aa7b3b0e5d12a0b0767a4494ad1a18","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999017495.SGD","LU2746668461.USD","LU1057294990.SGD","LU0385154629.USD","LU0965509101.SGD","03347","LLY","SG9999001176.USD","LU0310799852.SGD","LU1868836757.USD","MRNA","LU0342679015.USD","09939","LU0154236417.USD","BK4534","IE00B1XK9C88.USD","LU1718418525.SGD","LU1066051225.USD","LU1153585028.USD","BK4532","BK1583","LU0738911758.USD","LU1894683348.USD","LU1804176565.USD","LU2279689827.SGD","LU1127390331.HKD","LU0882574139.USD","PFE","LU0061475181.USD","LU0106261372.USD","LU0225284248.USD","LU1934455863.HKD","LU0211327993.USD","LU2361044949.HKD","LU0029864427.USD","LU1670628061.USD","LU1506573853.SGD","159646","IE00B775H168.HKD","IE00B19Z9P08.USD","UNH","LU0006306889.USD","LU0353189763.USD","NVO","SG9999015945.SGD","LU1037948541.HKD","LU1732800096.USD","LU0149725797.USD","IE00BK4W5L77.USD","159938"],"gpt_icon":0},{"id":"2549957695","title":"礼来7月7日成交额为19.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549957695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549957695?lang=zh_cn&edition=full","pubTime":"2025-07-08 11:17","pubTimestamp":1751944632,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日,礼来成交额为19.85亿美元,成交额较昨日增加75.62%,当日成交量为257.69万股。礼来于2025年7月7日跌1.0%,报772.87美元,该股过去5个交易日跌0.33%,年初至今涨0.48%,过去60日涨6.63%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-07|19.85亿|75.62%|257.69万|#|2025-07-03|11.30亿|-26.48%|145.08万|#|2025-07-02|15.37亿|-27.88%|197.83万|#|2025-07-01|21.32亿|-10.01%|273.40万|#|2025-06-30|23.69亿|-26.37%|304.15万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708111717a43d0c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708111717a43d0c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1988902786.USD","LU1989771016.USD","SG9999014914.USD","BK4534","IE0009355771.USD","LU2471134879.HKD","LU2324357040.USD","LU1868836914.USD","LU2471134523.USD","BK4007","IE0004445239.USD","LU1868837300.USD","LU2461242641.AUD","LU2462157665.USD","LLY","SGXZ51526630.SGD","BK4581","LU0786609619.USD","LU1868837136.USD","LU0882574139.USD","LU0471298694.HKD","LU0471298777.SGD","LU1983299246.USD","LU1974910355.USD","LU0061475181.USD","LU0417517546.SGD","LU0234572021.USD","LU2456880835.USD","SG9999014898.SGD","LU1069344957.HKD","SGXZ31699556.SGD","LU0203201768.USD","LU1551013342.USD","LU2491050154.USD","IE00BK4W5L77.USD","LU1127390331.HKD","LU1868836591.USD","IE00B2B36J28.USD","LU0385154629.USD","LU2089984988.USD","LU1093756168.USD","LU2265009873.SGD","LU0109391861.USD","IE00B4R5TH58.HKD","LU2063271972.USD","LU0320765992.SGD","LU1035775433.USD","LU2237443549.SGD","LU0006306889.USD","LU2552382132.HKD"],"gpt_icon":1},{"id":"2549309847","title":"预测:2030年畅销药和世界药企排名","url":"https://stock-news.laohu8.com/highlight/detail?id=2549309847","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549309847?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:03","pubTimestamp":1751857385,"startTime":"0","endTime":"0","summary":"根据Evaluate的一份新报告,到2030年,处方药总销售额预计将增长到1.75万亿美元,预计GLP-1将在2024年至2030年期间增长20%销售额。根据预测,礼来的Mounjaro和Zepbound,预计到2030年将赚取620亿美元。随着药物排名的变化,各大药企排名也将重新洗牌,Evaluate预测2030年,凭借GLP-1领域的强劲增长趋势,礼来和诺和诺德将迅速超越2024年处方药销售领域的行业领先者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707111242a43ae0a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707111242a43ae0a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4532","LU1934455277.USD","LU0122379950.USD","IE00BJT1NW94.SGD","LU1066051811.HKD","SG9999014567.USD","LU0965508806.USD","LU1116320737.USD","LU1037948897.HKD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2361044949.HKD","SG9999015358.SGD","IE00B4R5TH58.HKD","LU0965509010.AUD","LU1023059063.AUD","LU2023250843.SGD","MRK","IE000M9KFDE8.USD","LU2461242641.AUD","SG9999002224.SGD","LU0985320562.USD","LU1093756325.SGD","LU0234572021.USD","LU1037948541.HKD","IE0009355771.USD","IE00BKVL7J92.USD","LU0965509283.SGD","BK4599","LU0211331839.USD","NVO","LU1066053197.SGD","SG9999014542.SGD","LU1917777945.USD","SG9999014575.USD","LU1929549753.HKD","SG9999013999.USD","LU1585245621.USD","BK4516","LU1066051498.USD","LU1989771016.USD","BK4533","LU1989772923.USD","IE0002141913.USD","LLY","BP","LU0320765489.SGD","LU1941712264.USD","LU0072461881.USD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2549327269","title":"伴随着国产GLP-1减重药玛仕度肽(商品名:信尔美)的商业化落地国内减重药市场格局迎来了新的变化。全球两大减重药巨头诺和","url":"https://stock-news.laohu8.com/highlight/detail?id=2549327269","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549327269?lang=zh_cn&edition=full","pubTime":"2025-07-06 19:41","pubTimestamp":1751802085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0354030438.USD","LU2552382132.HKD","LU0672654240.SGD","LU1868837300.USD","159992","BK4588","LU2237443465.HKD","SG9999015978.USD","BK1574","IE00B1BXHZ80.USD","LU0096364046.USD","NVO","LU1069344957.HKD","IE00BJJMRZ35.SGD","LLY","SG9999014914.USD","LU2471134796.USD","IE00BJLML261.HKD","BK4581","BK4532","IE00B4R5TH58.HKD","SG9999015952.SGD","SGXZ81514606.USD","LU2236285917.USD","LU2552382215.SGD","SG9999001176.SGD","LU2328871848.SGD","LU2237443895.HKD","LU2063271972.USD","06978","GLP","LU2237438978.USD","01801","LU0122379950.USD","GB00BDT5M118.USD","BK4599","LU0320765059.SGD","LU1989771016.USD","YINN","BK1589","LU2324357040.USD","LU2361045086.USD","LU2361044865.SGD","LU1093756168.USD","LU0689472784.USD","LU2471134952.CNY","LU0094547139.USD","IE00BK4W5M84.HKD","LU0256863811.USD","LU1917777945.USD"],"gpt_icon":0},{"id":"2549452325","title":"减重赛道“人满为患”:中国药企试图“后来居上”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2549452325","media":"大洋网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549452325?lang=zh_cn&edition=full","pubTime":"2025-07-06 10:22","pubTimestamp":1751768520,"startTime":"0","endTime":"0","summary":"减重赛道已经是“人满为患”——老牌外资“双雄”诺和诺德的司美格鲁肽以及礼来的替尔泊肽在中国市场打得火热,线上线下平台都在积极铺货,原料药、产能问题也都在解决;与此同时,中国药企也试图“弯道超车”,掀起下一波治疗热点。据悉,玛仕度肽可用于成人肥胖或超重患者的长期体重控制,这是全球首个获批的GCG/GLP-1双受体激动减重药物。替尔泊肽可改善中度至重度阻塞性睡眠呼吸暂停肥胖成人患者的睡眠障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706104910979b89d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250706104910979b89d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1267930730.SGD","LU0689472784.USD","LU1551013425.SGD","LU0203202063.USD","LLY","LU1720051017.SGD","LU2361045086.USD","LU0471298777.SGD","LU2063271972.USD","SG9999014880.SGD","LU1868837136.USD","BK4581","LU1057294990.SGD","01801","LU2462157665.USD","LU0266013472.USD","LU0238689110.USD","LU0203201768.USD","BK4599","LU1366192091.USD","SG9999015952.SGD","LU2491050154.USD","LU1548497426.USD","LU1093756325.SGD","LU0316494557.USD","LU2471134523.USD","LU1720051108.HKD","LU2491050071.SGD","NVO","LU1868836757.USD","LU2264538146.SGD","LU2357305700.SGD","SGXZ57979304.SGD","LU0882574139.USD","LU0320765059.SGD","IE00B1BXHZ80.USD","LU1232071149.USD","LU0889565916.HKD","LU0640476718.USD","BK4516","LU2552382132.HKD","LU0289739699.SGD","LU0820561909.HKD","LU0109394709.USD","LU1061106388.HKD","LU0256863811.USD","BK4534","LU1974910355.USD","LU0708995401.HKD","BK4007","GB00BDT5M118.USD","BK4585"],"gpt_icon":1},{"id":"2548735332","title":"从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变","url":"https://stock-news.laohu8.com/highlight/detail?id=2548735332","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548735332?lang=zh_cn&edition=full","pubTime":"2025-07-04 11:21","pubTimestamp":1751599276,"startTime":"0","endTime":"0","summary":"文 | 医曜司美格鲁肽与替尔泊肽均成为“药王级”产品,似乎GLP-1已然兑现了市场对它的期待。两大行业巨头礼来与诺和诺德,看似稳坐云端宝座,实则危机四伏,各路豪强对GLP-1下半场虎视眈眈。GLP-1争夺战并未结束,即将开启的下半场或将出现更大规模的拼杀。这一结果使CagriSema成为首个在III期临床试验中实现超过20%减重效果的双靶点代谢药物组合,被业界视为GLP-1发展的关键里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704112548a72de8ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704112548a72de8ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0689472784.USD","LU1551013425.SGD","LU0058720904.USD","LLY","LU0203202063.USD","LU1917777945.USD","SG9999014880.SGD","LU1868837300.USD","LU2361044865.SGD","SG9999015945.SGD","LU0943347566.SGD","LU0122379950.USD","LU2462157665.USD","BK4533","LU0238689110.USD","LU0203201768.USD","SG9999015952.SGD","SGXZ81514606.USD","LU2461242641.AUD","LU2491050154.USD","LU0417517546.SGD","LU1093756325.SGD","LU0316494557.USD","LU1720051108.HKD","LU2456880835.USD","LU2324357040.USD","BK4588","LU1035775433.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU2237443622.USD","LU0471298694.HKD","GLP","LU0320765059.SGD","LU0006306889.USD","LU1232071149.USD","IE0004445239.USD","LU0256863902.USD","SGXZ99366536.SGD","LU0289739699.SGD","LU0823416689.USD","LU0323591593.USD","LU0256863811.USD","SG9999001176.SGD","LU1069344957.HKD","IE00B4R5TH58.HKD","BK4534","LU2750360997.AUD","BK4007","LU0385154629.USD"],"gpt_icon":1},{"id":"2548733304","title":"从“减重效率”到“减重质量”,GLP-1“战争”下半场逻辑剧变","url":"https://stock-news.laohu8.com/highlight/detail?id=2548733304","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548733304?lang=zh_cn&edition=full","pubTime":"2025-07-04 07:36","pubTimestamp":1751585809,"startTime":"0","endTime":"0","summary":"司美格鲁肽与替尔泊肽均成为“药王级”产品,似乎GLP-1已然兑现了市场对它的期待。两大行业巨头礼来与诺和诺德,看似稳坐云端宝座,实则危机四伏,各路豪强对GLP-1下半场虎视眈眈。GLP-1争夺战并未结束,即将开启的下半场或将出现更大规模的拼杀。根据辉瑞预测,2030年GLP-1市场的规模将达到约900亿美元,口服产品预计到2030年将占据GLP-1市场约30%的份额,主要原因是患者对口服制剂的偏好较高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704074156a72d7aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704074156a72d7aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1585","AMGN","BK1100","02142","02696","06855","03692","BK1589","LLY","06160","NVO","00853","02269","06618","01952","01801","01877","02359","600276","02096"],"gpt_icon":1},{"id":"2548367659","title":"太平洋医药日报:礼来替尔泊肽新适应症获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2548367659","media":"太平洋证券股份...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548367659?lang=zh_cn&edition=full","pubTime":"2025-07-04 00:00","pubTimestamp":1751558400,"startTime":"0","endTime":"0","summary":"替尔泊肽是首个且目前唯一获批的 GIP 和 GLP-1 双受体激动剂药物,此次获批主要基于SURMOUNT-OSA 临床3 期试验的结果。数据显示,对于未使用PAP 治疗的成人患者中,替尔泊肽在减少呼吸暂停低通气的效果是安慰剂的5 倍,即替尔泊肽可使每小时呼吸暂停低通气次数减少27 次,而安慰剂仅减少5 次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041712599799b675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507041712599799b675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001176.USD","LU0882574055.USD","LU0061475181.USD","LU0266013472.USD","LU2237443895.HKD","LU2211815571.USD","LLY","LU1623119135.USD","LU0943347566.SGD","LU2471134796.USD","LU0203202063.USD","LU1548497426.USD","LU1551013342.USD","LU2324357040.USD","LU0471298777.SGD","LU1069344957.HKD","LU1064131342.USD","LU2471134879.HKD","LU0889565916.HKD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU2265009873.SGD","BK4516","IE00BK4W5M84.HKD","LU0354030511.USD","LU1989771016.USD","LU2361044949.HKD","LU0820561909.HKD","LU2264538146.SGD","LU0320765059.SGD","LU0471298694.HKD","LU1868836914.USD","LU2237443622.USD","GB00BDT5M118.USD","IE00BJLML261.HKD","SGXZ81514606.USD","LU2237443549.SGD","LU2357305700.SGD","LU2468319806.SGD","SG9999013999.USD","LU0096364046.USD","LU2237443978.SGD","LU2750360997.AUD","LU0882574139.USD","LU0079474960.USD","IE00B4R5TH58.HKD","LU2491049909.HKD","LU1232071149.USD","LU1267930730.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":1},{"id":"2548887672","title":"从礼来获悉其GIP/GLP-1药物替尔泊肽注射液获得中国国家药品监督管理局(NMPA)批准成为首个且目前唯一用于治疗成人","url":"https://stock-news.laohu8.com/highlight/detail?id=2548887672","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548887672?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:26","pubTimestamp":1751531207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","BK4533","IE00B2B36J28.USD","SG9999001176.SGD","LU1035775433.USD","LU0122379950.USD","SG9999014914.USD","SG9999017495.SGD","LU2361044865.SGD","LU1623119135.USD","BK4534","LU1023059063.AUD","GLP","LU1917777945.USD","LU1548497426.USD","SG9999013999.USD","LU2211815571.USD","LU1712237335.SGD","IE0009355771.USD","LU1127390331.HKD","SG9999018857.SGD","LU0106261372.USD","LU0417517546.SGD","LU2361044949.HKD","LU1868836757.USD","LU0882574139.USD","LU1291159041.SGD","SG9999014880.SGD","SG9999015986.USD","LU0320765992.SGD","SGXZ51526630.SGD","LU1983299246.USD","IE00BK4W5L77.USD","SG9999015978.USD","BK4590","LU1551013425.SGD","LU1974910355.USD","BK4516","LU2746668461.USD","LU0823416689.USD","LU0203202063.USD","LU1720051017.SGD","IE00BK4W5M84.HKD","LU2462157665.USD","LU0203201768.USD","LU0079474960.USD","LU0471298777.SGD","LLY","LU1804176565.USD","LU0266013472.USD"],"gpt_icon":0},{"id":"2548787642","title":"礼来替尔泊肽获批第三项适应证 填补睡眠呼吸暂停药物治疗领域空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2548787642","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548787642?lang=zh_cn&edition=full","pubTime":"2025-07-03 16:07","pubTimestamp":1751530063,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0689472784.USD","LU0786609619.USD","LLY","IE00BJLML261.HKD","LU0096364046.USD","LU2265009873.SGD","LU1551013342.USD","LU2360106947.USD","LU1064131342.USD","LU2602419157.SGD","SGXZ81514606.USD","LU2237438978.USD","BK4599","LU2461242641.AUD","LU0316494557.USD","LU2471134879.HKD","LU2471134523.USD","LU1988902786.USD","LU2237443465.HKD","LU0466842654.USD","LU2324357040.USD","LU2456880835.USD","LU0456855351.SGD","LU2471134952.CNY","LU0820561818.USD","LU2112291526.USD","LU0882574055.USD","LU0471298694.HKD","GB00BDT5M118.USD","LU0061475181.USD","GLP","LU0708995401.HKD","LU0320765059.SGD","IE00B1BXHZ80.USD","LU0097036916.USD","LU1232071149.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0640476718.USD","LU2552382058.USD","LU2552382132.HKD","LU2236285917.USD","LU0109394709.USD","LU0256863811.USD","LU2552382215.SGD","LU1280957306.USD","IE00B4R5TH58.HKD","LU0094547139.USD","BK4007","LU0385154629.USD"],"gpt_icon":0},{"id":"2548918875","title":"礼来宣布穆峰达(替尔泊肽注射液)获得中国国家药品监督管理局(NMPA)批准成为首个且目前唯一用于治疗成人肥胖患者的中度至","url":"https://stock-news.laohu8.com/highlight/detail?id=2548918875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548918875?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:50","pubTimestamp":1751529022,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0354030438.USD","LU2552382132.HKD","LU0672654240.SGD","LU0882574055.USD","LU0097036916.USD","LU1868837300.USD","LU1983299246.USD","LU0198837287.USD","LU0058720904.USD","LU0456855351.SGD","BK4588","LU2360106947.USD","SG9999018865.SGD","LU2265009873.SGD","LU2552382058.USD","LLY","LU2264538146.SGD","LU1093756325.SGD","BK4581","LU0109391861.USD","LU0471298694.HKD","SG9999015952.SGD","LU2211815571.USD","LU1551013425.SGD","LU1291159041.SGD","LU0234572021.USD","LU1720051017.SGD","LU2236285917.USD","LU2491050071.SGD","LU0323591593.USD","LU0266013472.USD","LU2237438978.USD","IE0004445239.USD","IE0009355771.USD","LU2602419157.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1366192091.USD","GB00BDT5M118.USD","LU0203201768.USD","LU2417539215.USD","SGXZ57979304.SGD","LU2462157665.USD","LU2357305700.SGD","BK4585","LU2361044865.SGD","LU1868836591.USD","LU0689472784.USD","LU1804176565.USD","LU1623119135.USD"],"gpt_icon":0},{"id":"2548534875","title":"重磅!礼来“替尔泊肽”又一适应症在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2548534875","media":"Insight数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548534875?lang=zh_cn&edition=full","pubTime":"2025-07-03 15:30","pubTimestamp":1751527805,"startTime":"0","endTime":"0","summary":"7 月 3 日,NMPA 官网显示,礼来制药GLP-1R/GIPR 双重激动剂“替尔泊肽”新适应症在华获批上市。未来,替尔泊肽仍是有望问鼎“药王”宝座的关键选手之一。该研究旨在评估每周一次皮下注射替尔泊肽与安慰剂相比,在 469 位中重度 OSA 肥胖成年患者中的疗效和安全性。结果表明,无论患者是否接受 PAP 治疗,替尔泊肽均能显著改善中重度 OSA 肥胖患者的睡眠呼吸暂停症状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153807a4ccc5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153807a4ccc5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","LU0109391861.USD","LU0114720955.EUR","BK4534","LU0106261372.USD","LU0203202063.USD","LU2063271972.USD","LU0094547139.USD","LU2324357040.USD","LU0354030438.USD","LU1868837300.USD","SG9999014898.SGD","LU0266013472.USD","LU1093756168.USD","LU2491050154.USD","SG9999018865.SGD","LU2491050071.SGD","SG9999014906.USD","IE00BFTCPJ56.SGD","LLY","LU1267930730.SGD","LU2468319806.SGD","IE00BK4W5L77.USD","LU1974910355.USD","LU0823416689.USD","IE0004445239.USD","LU0672654240.SGD","LU2471134952.CNY","LU0289739699.SGD","SG9999015978.USD","IE00B4R5TH58.HKD","LU2461242641.AUD","GB00BDT5M118.USD","LU1868836914.USD","LU2023250504.SGD","LU0882574139.USD","SG9999014914.USD","LU0943347566.SGD","IE00B2B36J28.USD","LU2237443622.USD","SGXZ99366536.SGD","IE0009355771.USD","LU2211815571.USD","LU0256863902.USD","LU1989771016.USD","LU1868836757.USD","LU0203201768.USD","LU0466842654.USD","IE00B1BXHZ80.USD","LU2361044865.SGD"],"gpt_icon":1},{"id":"2548382555","title":"礼来7月2日成交额为15.37亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382555","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548382555?lang=zh_cn&edition=full","pubTime":"2025-07-03 11:21","pubTimestamp":1751512886,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,礼来成交额为15.37亿美元,成交额较昨日减少27.88%,当日成交量为197.83万股。礼来于2025年7月2日涨0.44%,报779.28美元,该股过去5个交易日跌1.64%,年初至今涨1.32%,过去60日涨5.78%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-02|15.37亿|-27.88%|197.83万|#|2025-07-01|21.32亿|-10.01%|273.40万|#|2025-06-30|23.69亿|-26.37%|304.15万|#|2025-06-27|32.17亿|29.73%|411.51万|#|2025-06-26|24.80亿|3.81%|311.82万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703112133a72bc509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703112133a72bc509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU0266013472.USD","LU2237443622.USD","SG9999015986.USD","LU2361045086.USD","SG9999013999.USD","LU1983299246.USD","LU1989771016.USD","LU0256863902.USD","IE0002141913.USD","LLY","LU2112291526.USD","SG9999014914.USD","LU1814569148.SGD","LU1035775433.USD","LU2552382215.SGD","IE00BJT1NW94.SGD","LU2106854487.HKD","LU0471298694.HKD","LU1232071149.USD","LU0823416689.USD","SG9999014898.SGD","LU1366192091.USD","LU2237443895.HKD","BK4581","IE00B4R5TH58.HKD","SG9999015952.SGD","LU0122379950.USD","LU2236285917.USD","LU0466842654.USD","SG9999001176.SGD","LU0672654240.SGD","LU0786609619.USD","SGXZ57979304.SGD","LU0471298777.SGD","LU0096364046.USD","LU1974910355.USD","LU0109394709.USD","BK4533","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2471134523.USD","LU2237443549.SGD","LU2471134796.USD","LU0323591593.USD","LU1868837136.USD","LU0203202063.USD","LU1720051017.SGD","SGXZ99366536.SGD","SG9999001176.USD"],"gpt_icon":0},{"id":"2548817439","title":"周三(7月2日)美国科技股七巨头(Magnificent 7)指数涨1.26%报173.68点。特斯拉收涨4.97%脱离","url":"https://stock-news.laohu8.com/highlight/detail?id=2548817439","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548817439?lang=zh_cn&edition=full","pubTime":"2025-07-03 04:05","pubTimestamp":1751486737,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"61a61cee0c04f1a71f697c686fbd9a3f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4577","NVD3.UK","03145","NVDS","NVIW.SI","LU0795875169.SGD","NVDS.UK","NVDL","MACW.SI","TWmain","LU0162691827.USD","NQmain","USAW.SI","MSFT","AMD","LU0471298777.SGD","LU1496350502.SGD","LU0353189680.USD","LU1674673691.USD","BRK.B","BRK.A","GOOGL","GFS","TSM","2NVD.UK","AAPL","LU0082616367.USD","TSLA","NVDU","NVD2.UK","AMZN","LLY","NVD","NVDD","NVDY","META","FB","SNVD.UK","3NVD.UK","NVDA","TSLL","EWT","LU0211328371.USD","LU0359202008.SGD","LU2247934214.USD","XMAG","NVDX","GOOG","HK0000320264.USD","TSYW.SI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lilly.com","stockEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.0171},{"period":"3month","weight":0.0916},{"period":"6month","weight":-0.0162},{"period":"1year","weight":-0.1561},{"period":"ytd","weight":0.0193}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"礼来公司于1901年在印第安纳州注册成立,其前身是1876年由伊利·礼来上校在印第安纳州印第安纳波利斯创立的药品生产企业。公司发现,开发,制造和销售重要医药产品。公司的宗旨是将“关爱”与“发现”结合起来,为世界各地的人们创造更美好的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.511111,"avgChangeRate":0.012368},{"month":2,"riseRate":0.511111,"avgChangeRate":0.000157},{"month":3,"riseRate":0.6,"avgChangeRate":0.012761},{"month":4,"riseRate":0.565217,"avgChangeRate":0.020234},{"month":5,"riseRate":0.413043,"avgChangeRate":0.010692},{"month":6,"riseRate":0.608696,"avgChangeRate":0.023694},{"month":7,"riseRate":0.565217,"avgChangeRate":-0.000133},{"month":8,"riseRate":0.422222,"avgChangeRate":0.004313},{"month":9,"riseRate":0.444444,"avgChangeRate":0.001418},{"month":10,"riseRate":0.577778,"avgChangeRate":0.012708},{"month":11,"riseRate":0.733333,"avgChangeRate":0.026326},{"month":12,"riseRate":0.577778,"avgChangeRate":0.030474}],"exchange":"NYSE","name":"礼来","nameEN":"Eli Lilly"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"礼来,LLY,礼来股票,礼来股票老虎,礼来股票老虎国际,礼来行情,礼来股票行情,礼来股价,礼来股市,礼来股票价格,礼来股票交易,礼来股票购买,礼来股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"礼来(LLY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供礼来(LLY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}